CTOs on the Move

RBC Life Sciences

www.rbclifesciences.com

 
RBC Life Sciences, Inc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. RBC Life Sciences, Inc is based in Irving, TX. You can find more information on RBC Life Sciences, Inc at www.rbclifesciences.com
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Northeast Kidney Foundation

Over 26 million Americans suffer from chronic kidney disease (CKD), including 1.5 million New Yorkers.  Formed in 1972 as a philanthropic gift of Edwin and Rhoda Sperber, the Foundation provides services to patients, family members, the general public and clinical and academic professionals throughout the Northeast.  The mission of the Northeast Kidney Foundation is to improve the quality of life of those affected by kidney disease and related conditions through early identification, intervention, prevention and support services; to promote organ donation; and to empower those we serve to be an effective voice for better healthcare at the local, state and federal levels.

Boriken Neighborhood Health Ctr.

The Boriken - School Health Program has provided primary care services in East Harlem schools since 1983 The Program operates clinics which offer medical and mental health services in three elementary schools (Public Schools 7, 112 and 155).

Cardiovascular Research Foundation

The Cardiovascular Research Foundation (CRF) in New York City is an independent, non-profit academic institution dedicated to improving the survival and quality of life of patients with cardiovascular disease through research and education.

Legacy Press

Legacy Press is a Blackwood, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Histogenics

Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Histogenics` regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Histogenics` first investigational product candidate, NeoCart®, leverages its platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.